TRT(SH:600085) Cai Jing Wang·2026-02-25 08:14Core Viewpoint - Tongrentang (600085) has received approval from the Canadian Ministry of Health for product licenses for several traditional Chinese medicine products, indicating a potential expansion into the Canadian market [1] Group 1: Product Approval - The company’s subsidiary, Tongrentang Pharmaceutical Factory, has been granted a Class III product license for the following products: Erganqing Oral Liquid, Suoyang Gujing Wan, Ren Shen Jianpi Wan, and Dahuang Chongsu Wan [1] - These products must still complete additional administrative approvals, including Canadian production quality system certification, before they can be sold in Canada [1] Group 2: Impact on Business - The announcement states that the approval will not have a significant impact on the company's recent operating performance [1]